Evidence map›Paper›PMID 40577356›Full record

ReviewPlant biotechnology journal2026

Protein engineering strategies to optimise recombinant product synthesis and accumulation in Nicotiana benthamiana.

Maxim D Harding, Frank Sainsbury

Abstract readReview
In one paragraph

Review in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maxim D HardingInstitute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0003-1698-4780
Frank SainsburyCentre for Cell Factories and Biopolymers, Institute for Biomedicine and Glycomics, Griffith University, Nathan, Queensland, Australia.ORCID https://orcid.org/0000-0001-8152-3820

Funding

Australian Research Council FT230100084
6 · The paper itself

Abstract

In plant molecular farming, recombinant products include traditional protein targets, such as antibodies, antigens, and enzymes, but also increasingly refers to high-value peptides, and small molecules produced by heterologous enzymatic pathways. The efficient accumulation and purification of recombinant products requires stable expression and localisation to permissive subcellular environments. Here we discuss innovation in protein engineering and complementary subcellular engineering strategies to tailor Nicotiana benthamiana for recombinant production of proteins, peptides, and small molecules. Three broad themes emerge: (i) targeting proteins via translational fusion of signal sequences can be effectively paired with engineered subcellular environments or synthetic organelles to improve protein folding and stability; (ii) fusion partners can be used to increase accumulation, facilitate purification, or sometimes both, in the case of identified multifunctional protein domains; (iii) co-expression with heterologous enzymes to perform orthogonal post-translational modification can enable the synthesis of unique peptide products. Together, these are some of the strategies that can increase recombinant expression, facilitate complex maturation requirements, shield the product from host cell metabolic processes, or protect the host from toxic product accumulation. The future of protein engineering strategies in N. benthamiana will benefit from advances in other recombinant production systems, genome-wide synthetic biology approaches, and developments in computational protein design.

Indexed as

NicotianaProtein EngineeringRecombinant ProteinsMolecular FarmingPlant ProteinsPlants, Genetically ModifiedProtein Processing, Post-TranslationalPlant ProteinsRecombinant Proteinspost‐translational modificationProtein engineeringprotein fusionrecombinant proteinsubcellular compartmentsynthetic organelle

Identifiers

PMID40577356
PMCPMC12854907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.